News and Announcements
Quarterly Activities & Cashflow Report | Optiscan
- Published April 30, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights for the Quarter
- Met with the United States Food and Drug Administration seeking feedback for a 510(k) submission in Oral Cancer Surgery and/or Oral Cancer Screening.
- Progress in Oral Cancer Trials and Studies being led by Memorial Sloan Kettering Cancer Centre, Melbourne Dental School and Australian Centre for Oral Oncology Research and Education.
- Leading medical journal, Nature Biomedical Engineering, published study confirming potential of OptiScan technology.
- Revenue from Carl Zeiss Meditec of approximately $500k.
- Delivery of a FIVE2 (ViewnVivo) system to a university in Shanghai –OptiScan’s first China sale with
new distribution arrangements. - Receipt of $211k from financing of Research and Development Tax Credit.
To read the full quarterly report click here.
About Optiscan
OptiScan (ASX:OIL) is an Australian listed company and a pioneer in the development and application of endomicroscopic imaging technologies for medical markets. Our multi-patented confocal imaging technology can be used for both cancer screening and tumour margin detection in cancer surgery. Our device enables real-time, in vivo imaging at the cellular level in clinical applications, providing a “digital” biopsy. The benefits of this “digital” biopsy include monitoring of early stage disease, earlier identification of pre-cancer and the potential to reduce the time doctors, patients and operating theatres are required to wait for pathology results, the number of repeat surgeries and actual biopsies required.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
